SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cano Health, Inc. (CANO) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+17392.6%).
- Analyst consensus target $402.33 (+17392.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 39/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CANO
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-195.46
Book Value / Share$0.00
Revenue / Share$1,249.69
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$402.33 (+17392.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-17.86 |
$361.38M |
$-29.69M |
-8.2% |
| 2020 |
$-42.75 |
$831.58M |
$-71.06M |
-8.5% |
| 2021 |
$-24.54 |
$1.61B |
$-116.74M |
-7.3% |
| 2022 |
$-195.46 |
$2.74B |
$-428.39M |
-15.6% |
